Pixium Vision is a French-based company that is dedicated to developing innovative retinal implant systems for patients who have lost their vision. With the aim of restoring vision and improving the quality of life for patients, Pixium Vision is committed to advancing the field of neuroprosthetics through its revolutionary technology.
Retinal implants are a promising avenue for restoring vision in patients with retinal degenerative diseases. Pixium Vision’s implant systems use advanced technology to bypass damaged cells and stimulate the remaining healthy cells in the retina. The technology used by Pixium Vision is cutting-edge and could potentially offer a solution to millions of people around the world who are living with vision loss.
Retinal Implant System: IRIS1
Pixium Vision’s first implant device, IRIS1, is an epi-retinal implant that is designed to restore vision in patients with retinitis pigmentosa. The device works by stimulating the remaining healthy cells in the retina using a microchip that is implanted on the surface of the retina. The chip receives visual information from an external camera, which is then processed and sent to the brain through the optic nerve. Pixium Vision is currently conducting clinical trials for IRIS1 with the goal of obtaining the CE Mark.
Generation Implant System: IRIS2
Pixium Vision is also developing a second-generation implant system, IRIS2, which is based on the same format as IRIS1 but offers better visual acuity and features several breakthrough technologies. The system uses an advanced microchip that is designed to mimic the function of the natural retina, providing patients with more natural and vivid vision. IRIS2 is currently in development and is expected to offer significant improvements in visual acuity compared to IRIS1.
Retinal Implant System: IRIS3
Pixium Vision is also working on a sub-retinal implant system, IRIS3, which has the potential to significantly improve vision compared to IRIS1 and IRIS2. The system uses advanced technology to bypass damaged cells in the retina and stimulate the remaining healthy cells. The device is designed to be implanted under the retina, allowing it to directly stimulate the cells that are responsible for transmitting visual information to the brain. The system is still in the early stages of development, but it has the potential to revolutionize the field of retinal implants.
Pixium Vision is a company that is committed to developing innovative retinal implant systems to improve the lives of those who have lost their vision. With cutting-edge technology and a team of experts dedicated to advancing the field of neuroprosthetics, Pixium Vision is poised to make a significant impact on the lives of millions of people around the world. By restoring vision and improving the quality of life for patients, Pixium Vision is transforming the field of retinal implants and providing hope to those who have lost their sight.
Want to amplify your startup’s story? EU Startup News is your launchpad to reach startup founders, investors, and C-level execs across Europe. Discover our tailored promotional strategies such as Sponsored Articles and Partnerships. Click here to learn more or contact us directly at [email protected]. Join us, and let’s make your startup the talk of Europe!